Tag: market-over
-
Gilead wins U.S. nod for drug for all types of hepatitis C
(Reuters) – U.S. health regulators on Tuesday approved a combination drug by Gilead Sciences Inc that is the first available treatment for all six major forms of hepatitis C, advancing the company’s leadership in the field and sending its shares up almost 4 percent. Gilead has dominated the hepatitis C market over rivals AbbVie and…
-
Gilead wins U.S. nod for drug for all types of hepatitis C
(Reuters) – U.S. health regulators on Tuesday approved a combination drug by Gilead Sciences Inc that is the first available treatment for all six major forms of hepatitis C, advancing the company’s leadership in the field and sending its shares up almost 4 percent. Gilead has dominated the hepatitis C market over rivals AbbVie and…
-
Southeast Asian fires emitted most carbon since 1997: scientists
By Beh Lih Yi JAKARTA (Thomson Reuters Foundation) – Forest fires that blanketed Southeast Asia in thick haze last year released the greatest amount of climate-changing carbon since record blazes in 1997, producing emissions higher than in the whole of the European Union, scientists said on Tuesday. Singapore, Malaysia and northern Indonesia choked under a…